본문 바로가기
KERD
논문KCI 등재

망막정맥폐쇄환자에서 황반부종의 양상에 따른 단기 시력예후

Short-Term Visual Outcomes According to Patterns of Macular Edema in Retinal Vein Occlusion Patients

박가희|노인호
대한안과학회 (The Korean Ophthalmological Society)|2012.09|대한안과학회지 (Journal of The Korean Ophthalmological Society)|제53권 제9호|pp. 1276-1284

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

Macular edemaOptical coherence tomographyBevacizumabRetinal vein occlusion
주제분류안과학

초록

목적: 망막정맥폐쇄 환자에서 황반부종의 양상이 시력에 영향을 주는지에 대해 알아보고자 한다. 대상과 방법: 망막정맥폐쇄로 진단받은 33안을 빛간섭단층촬영에서 나타난 황반부종의 양상에 따라 분류하고 유리체강내 베바시주맙주입을 시행한 후 시력(logMAR)을 측정하여 비교 분석하였다. 결과: 대상안은 망막중심정맥폐쇄 9안, 망막분지정맥폐쇄 24안이었으며 평균 경과관찰기간은 3.6개월이었다. 국소적 황반부종을 보인15안은 0.61 ± 0.34에서 0.26 ± 0.29로 유의한 시력의 호전이 있었으나(p˂0.01) 전반적 황반부종을 보인 26안은 0.85 ± 0.44에서0.73 ± 0.37로 유의한 호전을 보이지 않았다(p=0.07). 또한 장액성 망막박리가 동반되지 않은 16안은 0.76 ± 0.43에서 0.38 ± 0.36로 유의하게 호전되었으나(p˂0.01) 장액성 망막박리가 동반된 17안은 0.73 ± 0.40에서 0.64 ± 0.42로 유의한 호전을 보이지 않았다(p=0.07). 결론: 국소적 황반부종 군과 장액성 망막박리가 동반되지 않은 군에서 유의한 시력의 호전을 보여 망막정맥폐쇄환자에서 황반부종의양상이 시력예후에 영향을 미치는 인자가 될 수 있을 것으로 보인다.

Abstract

Purpose: To study the short-term visual outcomes affected by the patterns of macular edema in retinal vein occlusion patients. Methods: In a retrospective study, 33 eyes of 33 consecutive patients with macular edema from retinal vein occlusion received an intravitreal injection of bevacizumab. Macular edema was classified according to OCT patterns and the effect on visual outcome evaluated: Diffuse macular edema (DME) vs. focal macular edema (FME), and macular edema with serous retinal detachment (SRD) vs. macular edema without serous retinal detachment (non-SRD). Results: Nine patients had CRVO, 24 patients had BRVO and the follow-up period was 3.6 months. In the FME group, the mean baseline BCVA was 0.61 ± 0.34 and the final BCVA was 0.26 ± 0.29, a difference that was statistically significant (p < 0.01). In the DME group, the mean baseline BCVA was 0.85 ± 0.44 and the final BCVA was 0.73 ± 0.37, a difference that was not statistically significant (p = 0.07). In the non-SRD group, the mean baseline BCVA was 0.76 ± 0.43 and the final BCVA was 0.38 ± 0.36, a difference that was statistically significant (p < 0.01). In the SRD group, the mean baseline BCVA was 0.73 ± 0.40 and the final BCVA was 0.64 ± 0.42, a difference that was not statistically significant (p = 0.07). Conclusions: Visual outcome was significantly better in the FME and non-SRD groups. The patterns of macular edema measured according to OCT were a prognostic factor for visual outcome.

참고문헌 (31)

  1. "Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group", Am J Ophthalmol, 98, pp.271~282 (1984)
  2. Hee MR, "Quantitative assessment of macular edema with optical coherence tomography", Arch Ophthalmol, 113, pp.1019~1029 (1995)
  3. Konno S, "Retinal thickness measurements with optical coherence tomography and the scanning retinal thickness analyzer", Retina, 21, pp.57~61 (2001)
  4. 길현경, "망막분지정맥폐쇄환자에서 유리체강내 트리암시놀론 주입술의 효과", 대한안과학회지, 45(12), pp.11~11 (2004), 대한안과학회
  5. Lee H, "Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion", Retina, 25, pp.551~555 (2005)
  6. Noma H, "Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6", Am J Ophthalmol, 140, pp.256~261 (2005)
  7. Priglinger SG, "Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial", Retina, 27, pp.1004~1012 (2007)
  8. Jaissle GB, "Bevacizumab for treatment of macular edema secondary to retinal vein occlusion", Ophthalmologe, 103, pp.471~475 (2006)
  9. Iturralde D, "Intravitreal bevacizumab(Avastin) treatment of macular edema in central retinalvein occlusion: a short-term study", Retina, 26, pp.279~284 (2006)
  10. Yang HN, "Clinical evaluation for branch retinal vein occlusion", J Korean Ophthalmol Soc, 33, pp.599~604 (1992)
  11. Green WR, "Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases", Trans Am Ophthalmol Soc, 79, pp.371~422 (1981)
  12. "Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group", Arch Ophthalmol, 115, pp.486~491 (1997)
  13. Rehak J, "Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities", Curr Eye Res, 33, pp.111~131 (2008)
  14. Aiello LP, "Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders", N Engl J Med, 331, pp.1480~1487 (1994)
  15. Funatsu H, "Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema", Ophthalmology, 113, pp.294~301 (2006)
  16. Rosenfeld PJ, "Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion", Ophthalmic Surg Lasers Imaging, 36, pp.336~339 (2005)
  17. Gündüz K, "Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion", Eye (Lond), 22, pp.1168~1171 (2008)
  18. Jaissle GB, "One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion", Graefes Arch Clin Exp Ophthalmol, 247, pp.27~33 (2009)
  19. Rabena MD, "Intravitreal bevacizumab(Avastin) in the treatment of macular edema secondaryto branch retinal vein occlusion", Retina, 27, pp.419~425 (2007)
  20. Ach T, "Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion", Graefes Arch Clin Exp Ophthalmol, 248, pp.155~159 (2010)
  21. 강석재, "망막분지정맥폐쇄에서 황반허혈에 동반된 황반부종의 시력 예후", 대한안과학회지, 43(9), pp.9~1628 (2002), 대한안과학회
  22. Wolf-Schnurrbusch UE, "Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion", Invest Ophthalmol Vis Sci, 52, pp.3334~3337 (2011)
  23. Ota M, "Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion", Am J Ophthalmol, 145, pp.273~280 (2008)
  24. Hoeh AE, "OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion", Graefes Arch Clin Exp Ophthalmol, 248, pp.1567~1572 (2010)
  25. Schatz H, "Retinal detachment secondary to branch vein occlusion: Part II", Ann Ophthalmol, 8, pp.1461~1471 (1976)
  26. 이승우, "망막분지정맥폐쇄환자에서 빛간섭단층계를 이용한 황반부종의 형태학적 관찰", 대한안과학회지, 46(6), pp.969~975 (2005), 대한안과학회
  27. Otani T, "Patterns of diabetic macular edema with optical coherence tomography", Am J Ophthalmol, 127, pp.688~693 (1999)
  28. Kang SW, "The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema", Am J Ophthalmol, 137, pp.313~322 (2004)
  29. Ahn JK, "AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS ARE ASSOCIATED WITH SEROUS MACULAR DETACHMENT SECONDARY TO BRANCH RETINAL VEIN OCCLUSION", RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 30, pp.281~286 (2010), Ophthalmic Communications Society. Inc
  30. Yamaguchi Y, "Serous macular detachment in branch retinal vein occlusion", Retina, 26, pp.1029~1033 (2006)
  31. Yamaike N, "Three-dimensional imaging of cystoid macular edema in retinal vein occlusion", Ophthalmology, 115, pp.355~362 (2008)

관련 논문AI추천

망막분지정맥폐쇄에서 황반부종 형태에 따른 유리체강내 베바시주맙 주입술 효과와 주입횟수 비교이동원, 장윤수대한안과학회 · 대한안과학회지2012 · 제53권 제8호망막분지정맥폐쇄에 동반된 황반부종에서 베바시주맙치료 결과유웅선, 정인영, 조용운, 최영제, 최유진대한안과학회 · 대한안과학회지2021 · 제62권 제9호망막분지정맥폐쇄에 동반된 황반부종의 자연경과와 유리체강내 베바시주맙 주입술 결과의 비교사공민, 오현주, 장우혁대한안과학회 · 대한안과학회지2013 · 제54권 제7호망막중심정맥폐쇄에 동반된 황반부종에서 라니비주맙 주입술의 단기 임상 효과신혜영, 지동현대한안과학회 · 대한안과학회지2011 · 제52권 제9호망막분지정맥폐쇄에 동반된 황반부종에서 유리체내 베바시주맙주입술 후 초기 시력 반응의 의의노동현, 류가형, 사공민, 이준엽대한안과학회 · 대한안과학회지2017 · 제58권 제8호망막분지정맥폐쇄에 동반된 황반부종에서 황반 허혈과조기치료가 시력 예후에 미치는 영향곽형우, 서경훈, 양지호, 유승영대한안과학회 · 대한안과학회지2014 · 제55권 제2호

이 간행물의 다른 논문 (24건)

가쪽눈꺼풀판띠고정술과 퀴커트 봉합술을 동시에 시행한 퇴행성 눈꺼풀속말림의 치료결과분석김상원, 노주헌, 이우석pp. 1213-1218눈물점 폐쇄에서 눈물점성형술과 Pigtail Probe를 이용한 실리콘관삽입술의 효과김상수, 김인근pp. 1219-1225마취법 차이에 따른 백내장 수술 후 눈꺼풀처짐의 발생 비교김영국, 김성진, 문지영pp. 1226-1230성인 코눈물관 부분폐쇄에서 실리콘관 삽입술 후 마이토마이신 점안의 효과정진구, 안민pp. 1231-1235원발 군날개절제술 후 영구양막이식술과 일시양막이식술의 비교김희준, 이상범pp. 1236-1246
원문 보기